ETR:SRT - Sartorius Aktiengesellschaft Stock Price Target and Predictions

  • Consensus Rating: N/A
  • Consensus Price Target: €0.00
  • Forecasted Upside: -100.00 %
  • Number of Analysts: 0
  • Breakdown:
  • 0 Sell Ratings
  • 0 Hold Ratings
  • 0 Buy Ratings
  • 0 Strong Buy Ratings
€387.50
▼ -10.5 (-2.64%)

This chart shows the closing price for SRT by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New Sartorius Aktiengesellschaft Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for SRT and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for SRT

Analyst Price Target is €0.00
▼ -100.00% Downside Potential
This price target is based on 0 analysts offering 12 month price targets for Sartorius Aktiengesellschaft in the last 3 months. The average price target is €0.00, with a high forecast of €0.00 and a low forecast of €10,000,000.00. The average price target represents a -100.00% upside from the last price of €387.50.

This chart shows the closing price for SRT for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart

Current Consensus is N/A

The current consensus among 0 investment analysts is to n/a stock in Sartorius Aktiengesellschaft. This rating has held steady since August 2019, when it changed from a Hold consensus rating.

Past Monthly Recommendations

Move your mouse over past months for details Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart

  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
12/30/2019
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
3/29/2020
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
6/27/2020
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
9/25/2020
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
12/24/2020
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
3/24/2021
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
5/23/2021
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
6/22/2021

Latest Recommendations

  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetDetails
9/5/2018Warburg ResearchSet Price TargetNeutral€141.00
8/9/2018CommerzbankSet Price TargetSell€101.00
8/8/2018UBS GroupSet Price TargetNeutral€142.00
8/1/2018Kepler Capital MarketsSet Price TargetSell€111.00
7/26/2018Hauck & AufhaeuserSet Price TargetSell€93.00
7/25/2018UBS GroupSet Price TargetNeutral€135.00
7/25/2018HSBCSet Price TargetSell€96.00
7/24/2018Kepler Capital MarketsSet Price TargetNeutral€78.00
7/24/2018Warburg ResearchSet Price TargetNeutral€141.00
7/24/2018Berenberg BankSet Price TargetNeutral€110.00
7/20/2018CommerzbankSet Price TargetSell€100.00
7/13/2018Deutsche Bank AktiengesellschaftSet Price TargetNeutral€125.00
6/26/2018Warburg ResearchSet Price TargetNeutral€141.00
6/15/2018CommerzbankSet Price TargetSell€100.00
6/5/2018HSBCSet Price TargetSell€94.00
5/30/2018HSBCSet Price TargetSell€94.00
5/28/2018Warburg ResearchSet Price TargetNeutral€141.00
5/25/2018Berenberg BankSet Price TargetNeutral€110.00
(Data available from 6/22/2016 forward)
Sartorius Aktiengesellschaft logo
Sartorius Aktiengesellschaft provides bioprocess solutions and lab products and services worldwide. The company offers biosensors and kits, compliance tools, systems software, label-free detection systems, and SPR systems; live-cell analysis systems, flow cytometry platform, and cell analysis reagents and consumables; and antibody and recombinant protein media, viral vaccines media, regenerative medicine media, general media, downstream buffer, microcarrier, and stem cell media and reagent products, as well as strong acids, bases, and alcohols and detergents. It also provides multi-parallel bioreactors, benchtop bioreactors, single-use bioreactors, stainless steel bioreactors, cell culture bioreactors, microbial bioreactors, and software apps for bioreactors; membranes, blotting products, filter papers, glass and quartz microfibre products, and filtration equipment; syringe filters; and filtration devices, ultrafiltration devices, sterile filtration devices, harvesting devices, analytical sample prep systems, buffer exchange systems, diagnostic sample prep systems, particle analysis systems, pharmaceutical filtration systems, protein DNA concentration systems, venting moisture barriers, clarification systems, buffer and media products, and membrane chromatography products. In addition, the company offers process filtration products; process filtration products; process chromatography products; fluid management products; process analytical technology and data analytics; industrial microbiology systems; water purification systems; weighing systems; pipetting and dispensing systems; OEM systems; and centrifuges. Further, it provides bioprocess development and engineering, protein expression system, media and process, testing, instrument, and validation services. It serves the life science research, biopharmaceutical manufacturing, quality control and testing, and applied industries. The company was founded in 1870 and is headquartered in Göttingen, Germany.
Read More

Today's Range

Now: €387.50
Low: €383.00
High: €398.00

50 Day Range

MA: €389.34
Low: €360.50
High: €420.00

52 Week Range

Now: €387.50
Low: €237.00
High: €470.00

Volume

1,513 shs

Average Volume

N/A

Market Capitalization

$13.26 billion

P/E Ratio

101.04

Dividend Yield

0.17%

Beta

N/A

Frequently Asked Questions

What sell-side analysts currently cover shares of Sartorius Aktiengesellschaft?

The following equities research analysts have issued stock ratings on Sartorius Aktiengesellschaft in the last year:
View the latest analyst ratings for SRT.

What is the current price target for Sartorius Aktiengesellschaft?

0 Wall Street analysts have set twelve-month price targets for Sartorius Aktiengesellschaft in the last year. has the lowest price target set, forecasting a price of €10,000,000.00 for Sartorius Aktiengesellschaft in the next year.
View the latest price targets for SRT.

What is the current consensus analyst rating for Sartorius Aktiengesellschaft?

Sartorius Aktiengesellschaft currently has from Wall Street analysts. The stock has a consensus analyst rating of "N/A."
View the latest ratings for SRT.

What other companies compete with Sartorius Aktiengesellschaft?

How do I contact Sartorius Aktiengesellschaft's investor relations team?

The company's listed phone number is 49 551 308 0. The official website for Sartorius Aktiengesellschaft is www.sartorius.com.